Abstract:Natural bisindole alkaloids such as Hyrtinadine A and Alocasin A, which are known to exhibit diverse bioactivities, provide promising chemical scaffolds for drug development. By optimizing the Masuda borylation–Suzuki coupling sequence, a library of various natural product-derived and non-natural (di)azine-bridged bisindoles was created. While unsubstituted bisindoles were devoid of antibacterial activity, 5,5′-chloro derivatives were highly active against methicillin-resistant Staphylococcus aureus (MRSA) and further Gram-positive pathogens at minimal inhibitory concentrations ranging from 0.20 to 0.78 μM. These compounds showed strong bactericidal killing effects but only moderate cytotoxicity against human cell lines. Furthermore, the two front-runner compounds 4j and 4n exhibited potent in vivo efficacy against MRSA in a mouse wound infection model. Although structurally related bisindoles were reported to specifically target pyruvate kinase in MRSA, antibacterial activity of 4j and 4n is independent of pyruvate kinase. Rather, these compounds lead to bacterial membrane permeabilization and cellular efflux of low-molecular-weight molecules.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00826?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00826</a>.MICs of compounds 4 against all tested bacteria strains (Table S1); cytotoxicity data of compounds 4j, 4n, and 4q against the human cell lines HEK293, HepG2, and CLS-54 (Table S2); SNPs present in MRSA resistant mutants (Table S3); MICs of compounds of different classes against MRSA resistant mutants and wild-type (Table S4); dose–response curve of compound 4r against MRSA (Figure S1); solubility assessment of compounds 4c, 4d, 4j, 4n, and 4r (Figure S2); absorption maxima of compounds 4c, 4d, 4j, 4n, and 4r (Figure S3); hemolytic activity of 4j and 4n on sheep red blood cells (Figure S4); stability evaluation of compound 4c (Figure S5); dose–response curves for 4d, 4n, 4q, and 4s against MRSA LAC WT and LAC Δpyk::ErmR in minimal medium M9 (Figure S6); studies describing optimization of reaction conditions (Scheme S1 and Table S5); analytical data of compounds 1a, 4a–4f, 4j, 4l–4n, 4p–4s, 4u, and 4v including 1H and 13C NMR spectra (Figures S7–S40) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00826/suppl_file/jm0c00826_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Phenothiazine Derivatives: The Importance of Stereoisomerism in the Tolerance and Efficacy of Antimicrobials

Anti-MRSA activity of chlorophenyl pyrrolo benzodiazepines compound

Milligram scale enantioresolution of promethazine and its main metabolites, determination of their absolute configuration and assessment of enantioselective effects on human SY-SY5Y cells

Polymyxin Stereochemistry and Its Role in Antibacterial Activity and Outer Membrane Disruption

Synthesis, 3D-QSAR, and Docking Studies of 1-Phenyl-1h-1,2,3-triazoles As Selective Antagonists for Β3 over Α1β2γ2 GABA Receptors

Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase

The Biological Activities of Polyether Ionophore Antibiotic Routiennocin is Independent of Absolute Stereochemistry

Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods

Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs

Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?

Subinhibitory Concentrations of Antibiotics Induce Phenazine Production in a Marine Streptomyces sp.

Total and Semisyntheses of Polymyxin Analogues with 2-Thr or 10-Thr Modifications to Decipher the Structure–Activity Relationship and Improve the Antibacterial Activity

Novel 1-Benzoazepine-Derived Michael Acceptor and Its Hetero-Adducts Active Against MRSA

Synthesis, Structure, and Antibacterial Activity of Novel 5-Arylpyrazole Derivatives

Two Novel Regioisomeric Series of Bis-pyrazolines: Synthesis, In Silico Study, DFT Calculations, and Comparative Antibacterial Potency Profile against Drug-Resistant Bacteria; MSSA, MRSA, and VRSA

Synergistic antibacterial effects of closantel and its enantiomers in combination with colistin against multidrug resistant gram-negative bacteria

Pharmacological Evaluation of Enantiomers of AZ11645373 against the P2X7 Receptor

Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome

Phenazine Production Promotes Antibiotic Tolerance and Metabolic Heterogeneity in Pseudomonas Aeruginosa Biofilms.

Nature-Inspired (di)Azine-Bridged Bisindole Alkaloids with Potent Antibacterial In Vitro and In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus